Cargando…
Enhanced protection of C57 BL/6 vs Balb/c mice to melanoma liver metastasis is mediated by NK cells
The B16F10 murine melanoma cell line displays a low expression of MHC class I molecules favoring immune evasion and metastases in immunocompetent C57 BL/6 wild-type mice. Here, we generated metastases to the liver, an organ that is skewed towards immune tolerance, by intrasplenic injection of B16F10...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5889278/ https://www.ncbi.nlm.nih.gov/pubmed/29632723 http://dx.doi.org/10.1080/2162402X.2017.1409929 |
_version_ | 1783312676638687232 |
---|---|
author | Foerster, Friedrich Boegel, Sebastian Heck, Rosario Pickert, Geetha Rüssel, Nina Rosigkeit, Sebastian Bros, Matthias Strobl, Stephanie Kaps, Leonard Aslam, Misbah Diken, Mustafa Castle, John Sahin, Ugur Tuettenberg, Andrea Bockamp, Ernesto Schuppan, Detlef |
author_facet | Foerster, Friedrich Boegel, Sebastian Heck, Rosario Pickert, Geetha Rüssel, Nina Rosigkeit, Sebastian Bros, Matthias Strobl, Stephanie Kaps, Leonard Aslam, Misbah Diken, Mustafa Castle, John Sahin, Ugur Tuettenberg, Andrea Bockamp, Ernesto Schuppan, Detlef |
author_sort | Foerster, Friedrich |
collection | PubMed |
description | The B16F10 murine melanoma cell line displays a low expression of MHC class I molecules favoring immune evasion and metastases in immunocompetent C57 BL/6 wild-type mice. Here, we generated metastases to the liver, an organ that is skewed towards immune tolerance, by intrasplenic injection of B16F10 cells in syngeneic C57 BL/6 compared to allogeneic Balb/c mice. Surprisingly, Balb/c mice, which usually display a pronounced M2 macrophage and Th2 T cell polarization, were ∼3 times more susceptible to metastasis than C57 BL/6 mice, despite a much higher M1 and Th1 T cell immune response. The anti-metastatic advantage of C57 BL/6 mice could be attributed to a more potent NK-cell mediated cytotoxicity against B16F10 cells. Our findings highlight the role of NK cells in innate anti-tumor immunity in the context of the liver – particularly against highly aggressive MHC I-deficient cancer cells. Moreover, the B16F10 model of melanoma liver metastasis is suited for developing novel therapies targeting innate NK cell related immunity in liver metastases and liver cancer. |
format | Online Article Text |
id | pubmed-5889278 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-58892782018-04-09 Enhanced protection of C57 BL/6 vs Balb/c mice to melanoma liver metastasis is mediated by NK cells Foerster, Friedrich Boegel, Sebastian Heck, Rosario Pickert, Geetha Rüssel, Nina Rosigkeit, Sebastian Bros, Matthias Strobl, Stephanie Kaps, Leonard Aslam, Misbah Diken, Mustafa Castle, John Sahin, Ugur Tuettenberg, Andrea Bockamp, Ernesto Schuppan, Detlef Oncoimmunology Original Research The B16F10 murine melanoma cell line displays a low expression of MHC class I molecules favoring immune evasion and metastases in immunocompetent C57 BL/6 wild-type mice. Here, we generated metastases to the liver, an organ that is skewed towards immune tolerance, by intrasplenic injection of B16F10 cells in syngeneic C57 BL/6 compared to allogeneic Balb/c mice. Surprisingly, Balb/c mice, which usually display a pronounced M2 macrophage and Th2 T cell polarization, were ∼3 times more susceptible to metastasis than C57 BL/6 mice, despite a much higher M1 and Th1 T cell immune response. The anti-metastatic advantage of C57 BL/6 mice could be attributed to a more potent NK-cell mediated cytotoxicity against B16F10 cells. Our findings highlight the role of NK cells in innate anti-tumor immunity in the context of the liver – particularly against highly aggressive MHC I-deficient cancer cells. Moreover, the B16F10 model of melanoma liver metastasis is suited for developing novel therapies targeting innate NK cell related immunity in liver metastases and liver cancer. Taylor & Francis 2017-12-26 /pmc/articles/PMC5889278/ /pubmed/29632723 http://dx.doi.org/10.1080/2162402X.2017.1409929 Text en © 2018 The Author(s). Published with license by Taylor & Francis Group, LLC http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way. |
spellingShingle | Original Research Foerster, Friedrich Boegel, Sebastian Heck, Rosario Pickert, Geetha Rüssel, Nina Rosigkeit, Sebastian Bros, Matthias Strobl, Stephanie Kaps, Leonard Aslam, Misbah Diken, Mustafa Castle, John Sahin, Ugur Tuettenberg, Andrea Bockamp, Ernesto Schuppan, Detlef Enhanced protection of C57 BL/6 vs Balb/c mice to melanoma liver metastasis is mediated by NK cells |
title | Enhanced protection of C57 BL/6 vs Balb/c mice to melanoma liver metastasis is mediated by NK cells |
title_full | Enhanced protection of C57 BL/6 vs Balb/c mice to melanoma liver metastasis is mediated by NK cells |
title_fullStr | Enhanced protection of C57 BL/6 vs Balb/c mice to melanoma liver metastasis is mediated by NK cells |
title_full_unstemmed | Enhanced protection of C57 BL/6 vs Balb/c mice to melanoma liver metastasis is mediated by NK cells |
title_short | Enhanced protection of C57 BL/6 vs Balb/c mice to melanoma liver metastasis is mediated by NK cells |
title_sort | enhanced protection of c57 bl/6 vs balb/c mice to melanoma liver metastasis is mediated by nk cells |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5889278/ https://www.ncbi.nlm.nih.gov/pubmed/29632723 http://dx.doi.org/10.1080/2162402X.2017.1409929 |
work_keys_str_mv | AT foersterfriedrich enhancedprotectionofc57bl6vsbalbcmicetomelanomalivermetastasisismediatedbynkcells AT boegelsebastian enhancedprotectionofc57bl6vsbalbcmicetomelanomalivermetastasisismediatedbynkcells AT heckrosario enhancedprotectionofc57bl6vsbalbcmicetomelanomalivermetastasisismediatedbynkcells AT pickertgeetha enhancedprotectionofc57bl6vsbalbcmicetomelanomalivermetastasisismediatedbynkcells AT russelnina enhancedprotectionofc57bl6vsbalbcmicetomelanomalivermetastasisismediatedbynkcells AT rosigkeitsebastian enhancedprotectionofc57bl6vsbalbcmicetomelanomalivermetastasisismediatedbynkcells AT brosmatthias enhancedprotectionofc57bl6vsbalbcmicetomelanomalivermetastasisismediatedbynkcells AT stroblstephanie enhancedprotectionofc57bl6vsbalbcmicetomelanomalivermetastasisismediatedbynkcells AT kapsleonard enhancedprotectionofc57bl6vsbalbcmicetomelanomalivermetastasisismediatedbynkcells AT aslammisbah enhancedprotectionofc57bl6vsbalbcmicetomelanomalivermetastasisismediatedbynkcells AT dikenmustafa enhancedprotectionofc57bl6vsbalbcmicetomelanomalivermetastasisismediatedbynkcells AT castlejohn enhancedprotectionofc57bl6vsbalbcmicetomelanomalivermetastasisismediatedbynkcells AT sahinugur enhancedprotectionofc57bl6vsbalbcmicetomelanomalivermetastasisismediatedbynkcells AT tuettenbergandrea enhancedprotectionofc57bl6vsbalbcmicetomelanomalivermetastasisismediatedbynkcells AT bockampernesto enhancedprotectionofc57bl6vsbalbcmicetomelanomalivermetastasisismediatedbynkcells AT schuppandetlef enhancedprotectionofc57bl6vsbalbcmicetomelanomalivermetastasisismediatedbynkcells |